{"id":"https://openalex.org/W2349794367","doi":null,"title":"Systematic Analysis of the Efficacy and Safety of Simvastantin Combined with Fenofibrate versus Only Simvastantin in the Treatment of Hyperlipidemia","display_name":"Systematic Analysis of the Efficacy and Safety of Simvastantin Combined with Fenofibrate versus Only Simvastantin in the Treatment of Hyperlipidemia","publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W2349794367","mag":"2349794367"},"language":"en","primary_location":{"id":"mag:2349794367","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTotal-ZGYA201512029.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764872640","display_name":"Zhongguo yaofang","issn_l":"1001-0408","issn":["1001-0408"],"is_oa":false,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4322615966","host_organization_name":"China Pharmacy Publishing House","host_organization_lineage":["https://openalex.org/P4322615966"],"host_organization_lineage_names":["China Pharmacy Publishing House"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Zhongguo yaofang","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022077845","display_name":"Luo Hai-don","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799425052","display_name":"Guangdong General Hospital","ror":"https://ror.org/03jpekd50","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2799425052"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Luo Hai-don","raw_affiliation_strings":["Guangdong General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guangdong General Hospital","institution_ids":["https://openalex.org/I2799425052"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5022077845"],"corresponding_institution_ids":["https://openalex.org/I2799425052"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.24219771,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/simvastatin","display_name":"simvastatin","score":0.996999979019165},{"id":"https://openalex.org/keywords/fenofibrate","display_name":"fenofibrate","score":1.0},{"id":"https://openalex.org/keywords/hyperlipidemia","display_name":"hyperlipidemia","score":0.8999999761581421},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7400000095367432},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.902999997138977},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.8799999952316284},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.9950000047683716},{"id":"https://openalex.org/keywords/total-cholesterol","display_name":"total cholesterol","score":0.6060000061988831},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8169999718666077},{"id":"https://openalex.org/keywords/lipid-lowering-efficacy","display_name":"lipid-lowering efficacy","score":0.7889999747276306}],"concepts":[{"id":"https://openalex.org/C2778110834","wikidata":"https://www.wikidata.org/wiki/Q419724","display_name":"Fenofibrate","level":2,"score":0.9456803798675537},{"id":"https://openalex.org/C2776329913","wikidata":"https://www.wikidata.org/wiki/Q670131","display_name":"Simvastatin","level":2,"score":0.9237743616104126},{"id":"https://openalex.org/C2779091943","wikidata":"https://www.wikidata.org/wiki/Q1079120","display_name":"Hyperlipidemia","level":3,"score":0.8166826963424683},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7584054470062256},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6236835718154907},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5873963236808777},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.5517753958702087},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.48542317748069763},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.4148937463760376},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4033421576023102},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.3647947907447815},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3600934147834778},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2216394543647766},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2349794367","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTotal-ZGYA201512029.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764872640","display_name":"Zhongguo yaofang","issn_l":"1001-0408","issn":["1001-0408"],"is_oa":false,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4322615966","host_organization_name":"China Pharmacy Publishing House","host_organization_lineage":["https://openalex.org/P4322615966"],"host_organization_lineage_names":["China Pharmacy Publishing House"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Zhongguo yaofang","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2377206140","https://openalex.org/W1990166147","https://openalex.org/W2348526171","https://openalex.org/W2383685038","https://openalex.org/W1988048988","https://openalex.org/W2351547016","https://openalex.org/W2353078578","https://openalex.org/W2379254208","https://openalex.org/W2346161482","https://openalex.org/W2004339051"],"abstract_inverted_index":{"OBJECTIVE:To":[0],"systematically":[1],"evaluate":[2],"the":[3,17,37,49,54,79,109,133],"clinical":[4,26],"efficacy":[5],"and":[6,21,31,57,84,130,149],"safety":[7,129],"of":[8,19,51,81,136],"simvastantin":[9,15],"combined":[10,42,114],"with":[11,43,115,127,146],"fenofibrate":[12,41],"versus":[13],"only":[14,46,121],"in":[16,86,108,123],"treatment":[18,50],"hyperlipidemia":[20],"provide":[22],"evidence-based":[23],"reference":[24],"for":[25,64],"treatment.":[27],"METHODS:CJFD,Wangfang":[28],"Database,VIP":[29],"Database":[30],"CBM":[32],"were":[33,67,89],"retrieved":[34],"to":[35,132,140],"collect":[36],"randomized":[38],"controlled":[39],"trials(RCT)of":[40],"simvastatin(test":[44],"group)versus":[45],"simvastatin(control":[47],"group)in":[48],"hyperlipidemia.":[52],"After":[53],"information":[55],"collection":[56],"quality":[58,135],"evaluation,Rev":[59],"Man":[60],"5.2":[61],"was":[62,98,104],"conducted":[63],"Meta-analysis.":[65],"RESULTS:There":[66],"totally":[68],"17":[69],"RCTs":[70],"involving":[71],"2":[72],"110":[73],"cases.":[74],"Meta-analysis":[75],"results":[76],"showed":[77],"that":[78],"levels":[80,126],"low-density":[82],"lipoprotein-cholesterol(LDL-C)[MD=-0.27,95%CI(-0.34,-0.20),P0.000],cholesterol[MD=-0.46,95%CI(-0.53,-0.39),P0.000]":[83],"triglyceride(TG)[MD=-1.37,95%CI(-1.52,-1.23),P0.000]":[85],"test":[87],"group":[88],"significantly":[90,99],"lower":[91],"than":[92,101,120],"control":[93,102],"group,and":[94],"high-density":[95],"lipoproteincholesterol(HDL-C)[MD=0.21,95%":[96],"CI(0.19,0.23),P0.000]":[97],"higher":[100],"group;there":[103],"no":[105],"significant":[106],"difference":[107],"adverse":[110],"reaction(ADR)incidence":[111],"[OR=0.93,95%CI(0.64,1.34),P=0.69].":[112],"CONCLUSIONS:Fenofibrate":[113],"simvastatin":[116,122],"is":[117],"more":[118],"effectively":[119],"reducing":[124],"lipid":[125],"good":[128],"tolerance.Due":[131],"low":[134],"included":[137],"studies,it":[138],"remains":[139],"be":[141],"further":[142],"verified":[143],"by":[144],"RCT":[145],"large":[147],"sample":[148],"high":[150],"quality.":[151]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-06-24T00:00:00"}